|August 5, 2014|
|09:34 EDT||FSLR, AA, TSLA, AAPL, CMI, GILD, TWTR, KO, SINA, BAC||Active equity options trading on open|
Active equity options trading on open according to Track Data: AAPL BAC TWTR TSLA SINA GILD AA KO CMI FSLR
News For AAPL;BAC;TWTR;TSLA;SINA;GILD;AA;KO;CMI;FSLR From The Last 14 Days
|September 25, 2015|
|13:36 EDT||AAPL||Qualcomm volatility low as shares trend lower|
Qualcomm (QCOM) current 30-day call option implied volatility is at 26, compared to a one-month ago level of 38, suggesting decreasing price movement for the chipmaker that appear poised to obtain more revenue from Apple's (AAPL) iPhone 6S devices.
|12:39 EDT||AAPL||Electronic contract manufacturers advance after Jabil reports earnings|
Shares of contract electronic manufacturers Flextronics International (FLEX), Sanmina (SANM), and Celestica (CLS) are advancing after peer Jabil Circuit (JBL) posted quarterly earning last night that easily surpassed analysts' estimates. WHAT'S NEW: Jabil Circuit reported better-than-anticipated profit and revenue in the fourth quarter as revenue in its Diversified Manufacturing Services segment increased 47% on a year-over-year basis, and represented 41% of total company revenue. Jabil reported Q4 earnings per share of 53c on revenue of $4.68B against analysts' estimates of 45c and $4.55B. On the company's Q4 earnings conference call, Chief Executive Officer Mark Mondello said he anticipates continued growth across its DMS business, as the company "captures additional opportunities" in the markets that DMS serves. Mondello noted that those markets include audio, healthcare, consumer packaging, mobility, wearable technologies, and accessories. WHAT'S NOTABLE: Looking ahead, the company sees DMS in the first quarter up 33% year-over-year and guided to Q1 results that were far ahead of analysts' estimates. Jabil said it sees Q1 EPS of 72c-88c on revenue of $5.1B-$5.3B. Analysts were expecting EPS of 61c on revenue of $4.91B. Jabil also guided to fiscal year 2016 EPS of $2.60 ahead of expectations of $2.37. ANALYST TAKE: After Jabil reported higher than expected Q4 EPS, Stifel notes that the company's guidance for its November quarter was significantly above expectations. The firm thinks the company is benefiting from increased purchases of its diversified manufacturing products by Apple (AAPL). Stifel says that Apple is using Jabil's products for many of its products, not just iPhones, and it expects other customers to ramp up their purchases of the company's DMS products. Stifel kept a $25 price target and Buy rating on the shares. PRICE ACTION: Shares of Jabil Circuit are advancing almost 15% to $22.43 in midday trading. OTHERS TO WATCH: Shares of other contract manufacturers are also advancing, with Flextronics up 1.5%, Sanmina jumping 2.8%, and Celestica higher by 1.35%
|11:58 EDT||TWTR||Stocks with call strike movement; TWTR NFLX|
Twitter (TWTR) January 32 call option implied volatility increased 2% to 53, Netflix (NFLX) January 115.7 call option implied volatility decreased 2% to 55 according to IVolatility.
|11:25 EDT||AAPL||Cirrus leads iPhone suppliers higher as analysts dissect 6S|
Cirrus Logic (CRUS), Skyworks (SWKS) and Qorvo (QRVO) are among the chipmakers that appear poised to obtain more revenue from Apple's (AAPL) iPhone 6S devices than from the previous generation of the market-leading smartphone. Research firms issued notes today based on their analysis of "teardowns" of the new phones after they went on sale for the first time, beginning in Australia. TEARDOWNS: Apple's common practice when rolling out its newest iPhone models is for Australia to be its first launch market. The unboxing of iPhones when they become available for sale for the first time anywhere in the world is a much anticipated event among the tech giant's fans, as well as by Apple-focused blogs and Wall Street analysts who follow the company. Websites like iFixit have become well known for their "teardowns" of the devices, where they purchase, take apart and analyze the way in which the device is made and how it differs from previous models. These teardowns are closely watched by analysts and can sometimes be catalysts for the stocks of iPhone component suppliers. CIRRUS: Barclays analyst Blayne Curtis says teardowns of Apple's iPhone 6S indicate Cirrus Logic secured both a smart codec and boosted amp win in the new phone. The company's content in each phone is likely towards the upper end of his $3.50-$4.00 estimate, Curtis tells investors, noting that he views this as better than expected. Curtis thinks the 6S content, coupled with the "several new growth drivers" Cirrus outlined at yesterday's technology day, could reverse the negative sentiment on the stock. He keeps an Overweight rating on the name with a $39 price target. OTHER WINNERS AND LOSERS: Skyworks and Qorvo saw their content rise 22% and 25% respectively, Curtis estimated. NXP Semiconductors (NXPI) is continuing to supply the NFC and Secure Element chips for the 6S devices, but is no longer providing the sensor hub, the analyst reported. The company will lose about 50c per iPhone as a result of this development, but it did know that it would no longer be providing the hub before it provided its guidance in July, according to Curtis. STMicroelectronics (STM) is no longer providing the secure MCU for the iPhone 6S, Curtis added. WHAT'S NOTABLE: Other companies that are supplying iPhone 6S components include Qualcomm (QCOM), Texas Instruments (TXN), and Avago (AVGO), iFixit reported. After conducting checks, Craig-Hallum analyst Anthony Stoss estimated that Skyworks will obtain about $6.50 of revenue per iPhone, up from about $5.50 previously, while Qorvo's revenue per device will rise to $6.25 from $5.75 and Avago will see its revenue per device increase to about $6.75 from about $6.50, Stoss believes. The firm kept Buy ratings on Skyworks, Avago, and Qorvo. PRICE ACTION: In morning trading, Cirrus shares jumped $4.36, or 16%, to $31.49, Skyworks added about 3% and Qorvo rose 4%. Meanwhile, NXP gained about 2% and STMicroelectronics advanced 2.5%.
|10:39 EDT||TWTR||Twitter falls, levels to watch|
The stock is down over 2.4% at time of writing to $25.98. At that price next support is at $25.02. Resistance is at $26.42.
|10:13 EDT||AAPL||Apple launch day lines generally as expected, says Piper Jaffray|
Piper Jaffray analyst Gene Munster said the line at the Apple store on 5th Avenue in New York was about 650 people long at 8 am EDT, compared to last year's record 1,880 people counted, but added that the shorter line was generally in-line with the firm's expectations. The analyst noted that iPhone "S" cycles have historically had shorter lines, that Apple has been promoting pre-orders and online sales, and that the addition of China as a launch country likely cut down on resellers that were in line. Munster said he's still comfortable with his 12M-13M unit estimate for the opening weekend and keeps an Overweight rating and $172 price target on Apple shares.
|10:06 EDT||AAPL||Cirrus Logic content in iPhone 6S better than expected, says Barclays|
Barclays analyst Blayne Curtis says teardowns of Apple's (AAPL) iPhone 6S indicate Cirrus Logic (CRUS) secured both a smart codec and boosted amp win in the new phone. The company's content in each phone is likely towards the upper end of his $3.50-$4.00 estimate, Curtis tells investors in a research note. He views this as better than expected. Curtis thinks the 6S content, coupled with the "several new growth drivers" Cirrus outlined at yesterday's technology day, could reverse the negative sentiment on the stock. He keeps an Overweight rating on the name with a $39 price target. Cirrus is up $3.68 to $30.81 in early trading.
|10:00 EDT||CMI||On The Fly: Analyst Initiation Summary|
Today's noteworthy initiations include: AGCO (AGCO) initiated with an Equal Weight at Barclays... ARM Holdings (ARMH) initiated with a Buy at Stifel... Actuant (ATU) initiated with an Equal Weight at Barclays... Allison Transmission (ALSN) initiated with an Overweight at Barclays... Atara Biotherapeutics (ATRA) initiated with an Outperform at JMP Securities... Big Lots (BIG) initiated with a Buy at Citi... CNH Industrial (CNHI) initiated with an Underweight at Barclays... CareDx (CDNA) initiated with a Buy at Craig-Hallum... Caterpillar (CAT) initiated with an Equal Weight at Barclays... Cummins (CMI) initiated with an Underweight at Barclays... Deere (DE) initiated with an Underweight at Barclays... Genesis Energy (GEL) initiated with a Buy at Wunderlich... Joy Global (JOY) initiated with an Equal Weight at Barclays... Lincoln Electric (LECO) initiated with a Neutral at Baird... Manitowoc (MTW) initiated with an Equal Weight at Barclays... Navistar (NAV) initiated with an Underweight at Barclays... Nevro (NVRO) initiated with an Outperform at BMO Capital... PACCAR (PCAR) initiated with an Underweight at Barclays... PBF Energy (PBF) initiated with a Neutral at Goldman... PayPal (PYPL) initiated with a Buy at Canaccord... Quanex (NX) initiated with a Buy at Sidoti... Team Health (TMH) initiated with a Buy at Jefferies... Terex (TEX) initiated with an Equal Weight at Barclays... United Rentals (URI) initiated with an Overweight at Barclays... WABCO (WBC) initiated with an Equal Weight at Barclays.
|10:00 EDT||CMI||On The Fly: Analyst Downgrade Summary|
Today's noteworthy downgrades include: Atlas Air (AAWW) downgraded to In-Line from Outperform at Imperial Capital... Caterpillar (CAT) downgraded to Market Perform from Outperform at William Blair... Cummins (CMI) downgraded to Market Perform from Outperform at William Blair... Emerge Energy (EMES) downgraded after guidance withdrawal at Stifel... Exxon Mobil (XOM) downgraded to Underperform from Peer Perform at Wolfe Research... F5 Networks (FFIV) downgraded to Market Perform from Outperform at Raymond James... Internap (INAP) downgraded on earnings miss, negative outlook at Oppenheimer... Semtech (SMTC) downgraded to Neutral from Buy at MKM Partners... Silicon Laboratories (SLAB) downgraded to Neutral from Buy at MKM Partners... Superconductor Technologies (SCON) downgraded to Neutral from Buy at Ladenburg... Virgin America (VA) downgraded to Market Perform from Outperform at Cowen.
|09:48 EDT||AAPL||Apple iPhone 6S Plus teardown reveals chip suppliers, iFixit reports|
Subscribe for More Information
|09:47 EDT||AAPL||iPhone 6S teardown positive for Skyworks, Qorvo, says Craig-Hallum|
Craig-Hallum analyst Anthony Stoss says Apple (AAPL) iPhone 6S teardowns indicate content increases for Skyworks (SWKS), Qorvo (QRVO) and Avago (AVGO). Ross estimates Skyworks' content in the phone rose to $6.50 versus $5.50 in the first versions of iPhone 6, Qorvo's content rose to $6.25 from $5.75 and Avago's content rose to $6.75 from $6.50. He believes RF content is increasing and reiterates Buy ratings on all three names.
|09:34 EDT||TSLA, BAC, AAPL||Active equity options trading on open|
Active equity options trading on open: AAPL BAC FB NKE NFLX PFE AU TSLA
|08:28 EDT||CMI||Cummins downgraded to Market Perform from Outperform at William Blair|
Subscribe for More Information
|08:03 EDT||AAPL||Shopify announces new EMV credit card reader that accepts chip, pin, Apple Pay|
Subscribe for More Information
|07:34 EDT||GILD||Gilead says CHMP adopts poistive opinion for single tablet regimen Genvoya|
Gilead Sciences announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion on the company's Marketing Authorization Application for the investigational, once-daily single tablet regimen Genvoya for the treatment of HIV-1 infection. The data submitted in the MAA support the use of the regimen among adult and adolescent treatment-naive individuals, virologically suppressed adults who switch regimens and adults with mild-to-moderate renal impairment. The CHMP's recommendation will now be reviewed by the European Commission, which has the authority to approve medicines for use in the 28 countries of the European Union. If authorized, Genvoya would be Gilead's first single tablet regimen to contain TAF. The MAA for Genvoya is supported by 48-week data from two pivotal Phase 3 studies in which the regimen met its primary objective of non-inferiority compared to Gilead's Stribild among treatment-naive adult patients. In the studies, Genvoya demonstrated improvement in surrogate laboratory markers of renal and bone safety as compared to Stribild. The MAA is also supported by data from additional Phase 3 studies evaluating the TAF-based regimen among adolescents, virologically suppressed adult patients who switched to Genvoya and adult patients with mild-to-moderate renal impairment.
|07:27 EDT||AAPL||Jabil Circuit fiscal 2016 guidance 'solid,' says Stifel|
After Jabil reported higher than expected Q4 EPS, Stifel notes that the company's guidance for its November quarter was significantly above expectations. The firm thinks the company is benefiting from increased purchases of its diversified manufacturing products by Apple (AAPL). Stifel says that Apple is using Jabil's products for many of its products, not just iPhones, and it expects other customers to ramp up their purchases of the company's DMS products. Stifel keeps a $25 price target and Buy rating on the shares.
|06:47 EDT||AAPL||Apple October volatility flat as new iPhone hits stores|
Apple September weekly call option implied volatility is at 26, October weekly is at 30, October is at 29, November is at 33; compared to its 52-week range of 18 to 56, suggesting non-directional near term price movement and large November price movement.
|05:58 EDT||AAPL||Indian Prime Minister to meet with Apple, Google CEOs, WSJ reports|
Indian Prime Minister Narendra Modi will meet this weekend with Google (GOOG) CEO Sundar Pichai, Facebook (FB) founder Mark Zuckerberg and Apple (AAPL) CEO Tim Cook, among others, The Wall Street Journal reports. According to industry insiders, the tech executives will use the visit to push for better market access in India as well as clearer regulation on investment and startups. Reference Link
|05:55 EDT||AAPL||Apple shifts 30% of lens modules orders to Kantatsu, DigiTimes reports|
Subscribe for More Information
|05:51 EDT||CMI||Barclays starts U.S. Machinery space with Negative view|
Barclays analyst Robert Wertheimer rolled out coverage of the U.S. Machinery space with a Negative view. Of the fifteen companies he initiated in the sector, only two are Overweight rated. Wertheimer started five names at Underweight, his firm's equivalent of a sell. Consensus estimates are too high across the board with revenue for this cycle already peaking for most of machinery, the analyst told investors last night in a research note. He sees a sharper downturn for North American trucks than the consensus expects, with another peak level eight years away. And the tractor supercycle is only two years in a downturn, while the prior two supercycles saw seven consecutive down years in machinery sales, Wertheimer adds. Allison Transmission (ALSN) and United Rentals (URI) are the analyst's Overweight-rated stocks in the sector. Deere (DE), CNH Industrial (CNHI), Cummins (CMI), PACCAR (PCAR) and Navistar (NAV) are his Underweight rated names. Wertheimer also started with Equal Weight ratings shares of Actuant (ATU), AGCO (AGCO), Caterpillar (CAT), Joy Global (JOY), Lincoln Electric (LECO), Manitowoc (MTW), Terex (TEX) and WABCO (WBC).